Healthcare providers are increasingly looking for signs of opioid-induced adrenal insufficiency (OIAI) in their patients, according to a presentation made at the AACE annual meeting held in Los Angeles last week.
“At first, I was afraid, I was petrified. I kept thinking I could never live without you by my side…” so the song goes. That is sort of how I felt when my associate told me she was leaving.
Shared decision making should be employed in deciding on the best course of treatment for postmenopausal women with osteoporosis, experts say. In this slideshow, we highlight some of the key recommendations for diagnosing osteoporosis and assessing fracture risk in postmenopausal women.
Seasons change, but diabetes remains an intriguing year-round challenge. Here's a short quiz on diabetes treatment from Dr. Edward Chao.
To certify or not to certify, that is the question. There is no evidence that it improves patient care. And yet, the question often comes up in my discussions with colleagues: Should we recertify?
Are blood sugar levels moving targets? Should pregnant women be screened for thyroid cancer? And, will there soon be treatment to stave off those salt and sugar cravings? Learn more about these and other developments from endocrinology research in this news recap.
In very young children with type 1 diabetes, even a single episode of moderate/severe diabetic ketoacidosis (DKA) can potentially have long-term effects on cognitive abilities and brain growth, a study shows.
At ENDO 2019, two experts offered differing perspectives on optimal A1C targets. Blood sugar levels, one doctor said, should fall under 7 percent. Another physician argued for 7-8 percent. Learn more about the debate in this article.
Primary care providers, endocrinologists and obstetricians have been challenged with the question of whether to screen all pregnant women for thyroid disease. The debate springs primarily from unknown clinical implications of subclinical thyroid disease during pregnancy. This issue was addressed at ENDO 2019.
The American Thyroid Association guidelines recommend repeat fine-needle aspiration, molecular testing or diagnostic surgical resection if thyroid nodule size increases significantly, but a new study shows there is little evidence that significant tumor growth is a predictor of malignancy, especially in architectural atypia of undetermined significance (AUS-A) cases.
The hemoglobin A1C test underestimates the prevalence of diabetes in patients, shows new research presented at ENDO 2019.
The hormone oxytocin shows promise as a possible new treatment for obesity, according to research presented on Monday at ENDO 2019.
Diabetic retinopathy is the leading cause of blindness among working adults in the United States, but disease pathways may vary between patients, new research shows.
Fulminant type 1 diabetes is rare, sudden and often deadly. New research published in the journal Diabetes describes a key discovery that could lead to new treatments for this condition.
What drives your burnout? Better yet, how do you prevent yourself from getting burned out? Dr. Chao raises this important issue in this month's physician column.